The miR-25/Ataxin-3 axis provides a novel insight into the pathogenesis of human colon cancer, particularly with respect to promote proliferation and metastasis of colon cancer, and Ataxin-3 represents a potential therapeutic target for human colon cancer (Li et al., 2019). Here, ATXN3 is linked to colonic neoplasm.